Kestra Advisory Services’s Calithera Biosciences, Inc CALA Stock Holding History

Kestra Advisory Services’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$8K	–	2262
2022 Q1	$8K	Hold	1,000	–	–	﹤0.01%	1993
2021 Q4	$13K	Hold	1,000	–	–	﹤0.01%	2001
2021 Q3	$44K	Hold	1,000	–	–	﹤0.01%	2086
2021 Q2	$42K	Hold	1,000	–	–	﹤0.01%	1983
2021 Q1	$48K	Hold	1,000	–	–	﹤0.01%	1829
2020 Q4	$102K	Buy	+1,000	New	+$87.6K	﹤0.01%	1783

Other funds holding CALA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kestra Advisory Services's CALA Position: Q2 2022 in Review

Kestra Advisory Services sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 1,000 shares — an estimated $8K sold.

Kestra Advisory Services first reported a position in CALA in Q4 2020 and held it in 6 quarters. The position peaked at $102K in Q4 2020. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

Kestra Advisory Services reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
Kestra Advisory Services sold 1,000 Calithera Biosciences, Inc shares in Q2 2022, an estimated $8K.
Kestra Advisory Services first reported a position in Calithera Biosciences, Inc in Q4 2020 and held it in 6 quarters.
Kestra Advisory Services's Calithera Biosciences, Inc position peaked at $102K in Q4 2020.
28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Kestra Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.